Literature DB >> 19670087

Anatomical and functional correlates in major depressive disorder: the contribution of neuroimaging studies.

Silvia Rigucci1, Gianluca Serafini, Maurizio Pompili, Giorgio D Kotzalidis, Roberto Tatarelli.   

Abstract

Several studies suggested the neural networks modulating aspects of emotional behaviour to be implicated in the pathophysiology of mood disorders. These networks involve the medial prefrontal cortex (MPFC) and closely related areas in the medial and caudolateral orbital cortex (medial prefrontal network), amygdala, hippocampus, and ventromedial parts of the basal ganglia, where alterations in grey matter volume and neurophysiological activity are found in cases with recurrent depressive episodes. Such findings hold major implications for models of the neurocircuits that underlie depression. In particular, evidence from lesion analysis studies suggests that MPFC and related limbic and striato-pallido-thalamic structures organize emotional expression. The aim of this paper is to review the contribution of the most relevant studies with single photon emission tomography (SPECT), positron emission tomography (PET) and magnetic resonance imaging (MRI) to the understanding of pathophysiology of major depressive disorder (MDD), with particular focus on the reversibility of functional correlates with treatment.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 19670087     DOI: 10.1080/15622970903131571

Source DB:  PubMed          Journal:  World J Biol Psychiatry        ISSN: 1562-2975            Impact factor:   4.132


  47 in total

1.  Lithium monotherapy associated clinical improvement effects on amygdala-ventromedial prefrontal cortex resting state connectivity in bipolar disorder.

Authors:  Murat Altinay; Harish Karne; Amit Anand
Journal:  J Affect Disord       Date:  2017-06-27       Impact factor: 4.839

2.  The GABAergic deficit hypothesis of major depressive disorder.

Authors:  B Luscher; Q Shen; N Sahir
Journal:  Mol Psychiatry       Date:  2010-11-16       Impact factor: 15.992

3.  Effects of early-life abuse differ across development: infant social behavior deficits are followed by adolescent depressive-like behaviors mediated by the amygdala.

Authors:  Charlis Raineki; Millie Rincón Cortés; Laure Belnoue; Regina M Sullivan
Journal:  J Neurosci       Date:  2012-05-30       Impact factor: 6.167

Review 4.  Developmental risk I: depression and the developing brain.

Authors:  John M Weir; Arthurine Zakama; Uma Rao
Journal:  Child Adolesc Psychiatr Clin N Am       Date:  2012-02-17

5.  The association between financial hardship and amygdala and hippocampal volumes: results from the PATH through life project.

Authors:  Peter Butterworth; Nicolas Cherbuin; Perminder Sachdev; Kaarin J Anstey
Journal:  Soc Cogn Affect Neurosci       Date:  2011-05-06       Impact factor: 3.436

6.  A pattern of cerebral perfusion anomalies between major depressive disorder and Hashimoto thyroiditis.

Authors:  Maria Carolina Hardoy; Mariangela Cadeddu; Alessandra Serra; Maria Francesca Moro; Gioia Mura; Gisa Mellino; Krishna M Bhat; Gianmarco Altoé; Paolo Usai; Mario Piga; Mauro G Carta
Journal:  BMC Psychiatry       Date:  2011-09-13       Impact factor: 3.630

7.  White matter abnormalities: Insights into the pathophysiology of major affective disorders.

Authors:  Gianluca Serafini; Xenia Gonda; Zoltan Rihmer; Paolo Girardi; Mario Amore
Journal:  World J Radiol       Date:  2014-06-28

Review 8.  Purinergic system in psychiatric diseases.

Authors:  A Cheffer; A R G Castillo; J Corrêa-Velloso; M C B Gonçalves; Y Naaldijk; I C Nascimento; G Burnstock; H Ulrich
Journal:  Mol Psychiatry       Date:  2017-09-26       Impact factor: 15.992

Review 9.  Where in the brain is depression?

Authors:  Mayur Pandya; Murat Altinay; Donald A Malone; Amit Anand
Journal:  Curr Psychiatry Rep       Date:  2012-12       Impact factor: 5.285

Review 10.  Remodeling of axo-spinous synapses in the pathophysiology and treatment of depression.

Authors:  P Licznerski; R S Duman
Journal:  Neuroscience       Date:  2012-10-02       Impact factor: 3.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.